- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products.
NGL Fine-Chem delivered a strong Q1FY27, sustaining demand momentum with robust volumes. Revenue from operations jumped 33.57% year-on-year to ₹139.16 Cr, and Profit After Tax (PAT) surged 99.09% year-on-year to ₹18.40 Cr. Animal APIs remain the core, contributing 95% of revenue. EBITDA margin improved to 16.73% (+620 bps YoY). The...